Colon cancer blood test offers new screening option
Time:2024-05-21 19:49:36 Source:styleViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Analysis: Larson enters conversation with Verstappen as best drivers in the world
Next:Everybody may love Raymond, but Ray Romano loves Peter Boyle
You may also like
- Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
- Haiti's crisis rises to the forefront of elections in neighboring Dominican Republic
- A Palestinian converted to Judaism. An Israeli soldier saw him as a threat and opened fire
- The Biden administration is planning more changes to quicken asylum processing for new migrants
- Target to lower prices on basic goods in response to inflation
- Pictured: Terror suspect, 35, arrested over failure to disclose 'Isis
- The Biden administration is planning more changes to quicken asylum processing for new migrants
- Atlanta Dream moving two games vs Caitlin Clark
- Pentagon vows to keep weapons moving to Ukraine as Kyiv faces a renewed assault by Russia